{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "461",
                "471"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan dobry"
        },
        {
            "identifier": "T2",
            "position": [
                "360",
                "384"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zaburzeniami rytmu serca"
        },
        {
            "icd": "ICD10:I49.9",
            "identifier": "N1",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Zaburzenia rytmu serca, nieokre\u00c5\u009blone"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 13 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z zaburzeniami rytmu serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:3.75[10\\\\^3/ul]\n    RBC:4.37[10\\\\^6/ul]\n    HGB:13.0[g/dl]\n    HCT:38.2[%]\n    MCV:87.4[fl]\n    MCH:29.7[pg]\n    MCHC:34.0[g/dl]\n    PLT:237.0[10\\\\^3/ul]\n    RDW-SD:40.2[fl]\n    RDW-CV:12.6[%]\n    PDW:13.1[fl]\n    MPV:11.4[fl]\n    P-LCR:36.0[%]\n    PCT:0.3[%]\n    NEUTR#:1.62[10\\\\^3/ul]\n    NEUTR%:43.1[%]\n    LYMPH#:1.75[10\\\\^3/ul]\n    LYMPH%:46.7[%]\n    MONO#:0.31[10\\\\^3/ul]\n    MONO%:8.30[%]\n    EO#:0.06[10\\\\^3/ul]\n    EO%:1.60[%]\n    BASO#:0.01[10\\\\^3/ul]\n    BASO%:0.30[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.335\n    pCO2:49.1[mmHg]\n    BE:-0.30[mmol/L]\n    HCO3:25.5[mmol/L]\n    pO2:40.1[mmHg]\n    O2Sat:69.3[%]\n    Na - ABL:143[mmol/L]\n    K - ABL:4.4[mmol/L]\n    Cl - ABL:107[mmol/L]\n    Ca zj ABL:1.36[mmol/L]\n    Ht - ABL:36.9[%]\n    Hb ABL:12.0[g/dl]\n    FO2Hb:67.9[%]\n    FCOHb:1.2[%]\n    FMetHb:0.8[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:93[mg/dl]\n    mleczany:20[mg/dl]\n    COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:115.0[ng/ml]\nFibrynogen (F): FIB:2.47[g/L]\nAntytrombina III (ATIII): ATIII:119.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:42.2[s]\nINR: INR:1.2\nCzas protrombinowy (PT): PT:13.7[s]\nCzas trombinowy (TT): TT:35.9[s]\nKwas mlekowy: LAC:33.70[mg/dl]\nKwas mlekowy: LAC:121.80[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:80[%]\nKreatynina: CREA:0.60[mg/dl]\nMocznik: UREA:23.00[mg/dl]\nASPAT: AST:24.00[IU/L]\nALAT: ALT:28.00[IU/L]\nPLT z morfologii: PLT:237.0[10\\\\^3/ul]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:99.1[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:144[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:132.0[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nI49.2\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n88.721\n89.43\n89.541\n------------------------------------------------"
}